Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ari Melnick

Showing results (191-200 of 230) with videos related to

Pageof 23
Sort By:
Cancer Discovery|April 15, 2017
Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic ModifiersJacob L Glass, Duane Hassane, Bas J Wouters, et al.
Cancer Cell|March 8, 2024
ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesisDarko Barisic, Christopher R Chin, Cem Meydan, et al.
Leukemia|February 13, 2021
Genomic and evolutionary portraits of disease relapse in acute myeloid leukemiaFranck Rapaport, Yaseswini Neelamraju, Timour Baslan, et al.
Nature|July 6, 2012
IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigeneticsMasato Sasaki, Christiane B Knobbe, Joshua C Munger, et al.
Plos Genetics|June 28, 2012
Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemiaAltuna Akalin, Francine E Garrett-Bakelman, Matthias Kormaksson, et al.
Blood|April 13, 2019
PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomasMarién Pascual, María Mena-Varas, Eloy Francisco Robles, et al.
Plos Genetics|April 13, 2011
Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesisHector Alvarez, Joanna Opalinska, Li Zhou, et al.
Iscience|June 21, 2021
Combined epigenetic and metabolic treatments overcome differentiation blockade in acute myeloid leukemiaBarry M Zee, Kamrine E Poels, Cong-Hui Yao, et al.
Blood|March 31, 2021
KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomasJames Heward, Lola Konali, Annalisa D'Avola, et al.
Nature|March 25, 2015
Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemiaZhengshan Chen, Seyedmehdi Shojaee, Maike Buchner, et al.
Pageof 23

Showing results (191-200 of 230) with videos related to

Sort By:
Pageof 23
Cancer Discovery|April 15, 2017
Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic ModifiersJacob L Glass, Duane Hassane, Bas J Wouters, et al.
Cancer Cell|March 8, 2024
ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesisDarko Barisic, Christopher R Chin, Cem Meydan, et al.
Leukemia|February 13, 2021
Genomic and evolutionary portraits of disease relapse in acute myeloid leukemiaFranck Rapaport, Yaseswini Neelamraju, Timour Baslan, et al.
Nature|July 6, 2012
IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigeneticsMasato Sasaki, Christiane B Knobbe, Joshua C Munger, et al.
Plos Genetics|June 28, 2012
Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemiaAltuna Akalin, Francine E Garrett-Bakelman, Matthias Kormaksson, et al.
Blood|April 13, 2019
PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomasMarién Pascual, María Mena-Varas, Eloy Francisco Robles, et al.
Plos Genetics|April 13, 2011
Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesisHector Alvarez, Joanna Opalinska, Li Zhou, et al.
Iscience|June 21, 2021
Combined epigenetic and metabolic treatments overcome differentiation blockade in acute myeloid leukemiaBarry M Zee, Kamrine E Poels, Cong-Hui Yao, et al.
Blood|March 31, 2021
KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomasJames Heward, Lola Konali, Annalisa D'Avola, et al.
Nature|March 25, 2015
Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemiaZhengshan Chen, Seyedmehdi Shojaee, Maike Buchner, et al.
Pageof 23